Du, Yongzhong
Zhejiang University
5 papers on CoChatORCID 0000-0002-2137-4517
Most cited papers
- Verified
Enhanced efficiency of mitochondria-targeted peptide SS-31 for acute kidney injury by pH-responsive and AKI-kidney targeted nanopolyplexes
Liu, D., Jin, F., Shu, G., Xu, X., Qi, J., Kang, X., Yu, H., Lu, K., Jiang, S., Han, F., et al. (2019) · Biomaterials
Nanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery
Cited by 169
- Verified
Angiopep‐Conjugated Electro‐Responsive Hydrogel Nanoparticles: Therapeutic Potential for Epilepsy
Ying, X., Wang, Y., Liang, J., Yue, J., Xu, C., Lu, L., Xu, Z., Gao, J., Du, Y., & Chen, Z. (2014) · Angewandte Chemie International Edition
Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems
Cited by 143
- Verified
Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures
Wang, Y., Ying, X., Chen, L., Liu, Y., Wang, Y., Liang, J., Xu, C., Guo, Y., Wang, S., Hu, W., et al. (2016) · Neurotherapeutics
Epilepsy research and treatmentNanoparticle-Based Drug Delivery
Cited by 65
- Verified
Suppress orthotopic colon cancer and its metastasis through exact targeting and highly selective drug release by a smart nanomicelle
Zhu, C., Zhang, H., Li, W., Luo, L., Guo, X., Wang, Z., Kong, F., Li, Q., Yang, J., Du, Y., et al. (2018) · Biomaterials
Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics
Cited by 53
- Verified
A clinically acceptable strategy for sensitizing anti-PD-1 treatment by hypoxia relief
Jiang, M., Qin, B., Luo, L., Li, X., Shi, Y., Zhang, J., Luo, Z., Zhu, C., Guan, G., Du, Y., et al. (2021) · Journal of Controlled Release
Cancer Immunotherapy and BiomarkersCancer, Hypoxia, and Metabolism
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free